Balyasny Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $218M | Sell |
1,812,608
-374,652
| -17% | -$43.3M | 0.28% | 53 |
|
|
2025
Q4 | $230M | Buy |
2,187,260
+1,502,303
| +219% | +$141M | 0.29% | 51 |
|
|
2025
Q3 | $57.5M | Buy |
684,957
+669,324
| +4,281% | +$55.1M | 0.07% | 315 |
|
|
2025
Q2 | $1.24M | Sell |
15,633
-123,806
| -89% | -$9.84M | ﹤0.01% | 1962 |
|
|
2025
Q1 | $12.5M | Sell |
139,439
-1,516,688
| -92% | -$142M | 0.02% | 791 |
|
|
2024
Q4 | $165M | Buy |
1,656,127
+708,452
| +75% | +$73M | 0.25% | 78 |
|
|
2024
Q3 | $108M | Buy |
947,675
+942,687
| +18,899% | +$112M | 0.18% | 111 |
|
|
2024
Q2 | $618K | Sell |
4,988
-1,285,942
| -100% | -$166M | ﹤0.01% | 1978 |
|
|
2024
Q1 | $170M | Buy |
1,290,930
+767,966
| +147% | +$94.7M | 0.3% | 47 |
|
|
2023
Q4 | $57M | Sell |
522,964
-538,726
| -51% | -$55.9M | 0.11% | 247 |
|
|
2023
Q3 | $109M | Buy |
1,061,690
+126,466
| +14% | +$13.6M | 0.22% | 90 |
|
|
2023
Q2 | $108M | Buy |
935,224
+301,830
| +48% | +$34.3M | 0.24% | 89 |
|
|
2023
Q1 | $67.4M | Buy |
633,394
+345,871
| +120% | +$37.3M | 0.17% | 147 |
|
|
2022
Q4 | $31.9M | Buy |
287,523
+252,621
| +724% | +$25.8M | 0.09% | 308 |
|
|
2022
Q3 | $3.01M | Buy |
34,902
+595
| +2% | +$53.1K | 0.01% | 1274 |
|
|
2022
Q2 | $3.13M | Sell |
34,307
-73,233
| -68% | -$6.49M | 0.01% | 1157 |
|
|
2022
Q1 | $8.82M | Buy |
+107,540
| New | +$8.48M | 0.03% | 738 |
|
|
2021
Q3 | – | Sell |
-353,739
| Closed | -$26.9M | – | 2254 |
|
|
2021
Q2 | $27.5M | Sell |
353,739
-376,623
| -52% | -$28M | 0.13% | 212 |
|
|
2021
Q1 | $53.7M | Buy |
730,362
+145,518
| +25% | +$10.7M | 0.26% | 80 |
|
|
2020
Q4 | $45.6M | Buy |
584,844
+518,558
| +782% | +$39.7M | 0.25% | 85 |
|
|
2020
Q3 | $5.25M | Buy |
+66,286
| New | +$5.19M | 0.04% | 595 |
|
|
2020
Q1 | – | Sell |
-231,956
| Closed | -$20.1M | – | 1389 |
|
|
2019
Q4 | $20.1M | Buy |
+231,956
| New | +$19.1M | 0.12% | 258 |
|
|
2019
Q3 | – | Sell |
-419,597
| Closed | -$33.6M | – | 1427 |
|
|
2019
Q2 | $33.6M | Buy |
419,597
+382,417
| +1,029% | +$29.3M | 0.21% | 122 |
|
|
2019
Q1 | $2.95M | Buy |
37,180
+6,807
| +22% | +$509K | 0.02% | 719 |
|
|
2018
Q4 | $2.21M | Sell |
30,373
-411,589
| -93% | -$29.1M | 0.02% | 696 |
|
|
2018
Q3 | $29.9M | Buy |
441,962
+424,852
| +2,483% | +$27.1M | 0.14% | 208 |
|
|
2018
Q2 | $991K | Sell |
17,110
-700,698
| -98% | -$39.5M | ﹤0.01% | 1135 |
|
|
2018
Q1 | $37.3M | Buy |
717,808
+337,804
| +89% | +$18.2M | 0.16% | 187 |
|
|
2017
Q4 | $20.4M | Buy |
380,004
+80,765
| +27% | +$4.48M | 0.06% | 402 |
|
|
2017
Q3 | $18.3M | Buy |
299,239
+101,778
| +52% | +$6.17M | 0.07% | 338 |
|
|
2017
Q2 | $12.1M | Buy |
197,461
+47,049
| +31% | +$2.86M | 0.05% | 482 |
|
|
2017
Q1 | $9.12M | Sell |
150,412
-1,277,421
| -89% | -$77.5M | 0.04% | 527 |
|
|
2016
Q4 | $80.2M | Sell |
1,427,833
-1,745,102
| -55% | -$102M | 0.43% | 37 |
|
|
2016
Q3 | $189M | Buy |
3,172,935
+1,378,580
| +77% | +$80.6M | 1.09% | 3 |
|
|
2016
Q2 | $98.6M | Buy |
1,794,355
+1,149,204
| +178% | +$61.2M | 0.64% | 14 |
|
|
2016
Q1 | $32.6M | Buy |
645,151
+393,807
| +157% | +$19.3M | 0.19% | 159 |
|
|
2015
Q4 | $12.7M | Buy |
+251,344
| New | +$12.7M | 0.09% | 312 |
|
|
2015
Q3 | – | Sell |
-388,903
| Closed | -$21.1M | – | 1297 |
|
|
2015
Q2 | $21.1M | Sell |
388,903
-427,560
| -52% | -$24M | 0.13% | 204 |
|
|
2015
Q1 | $44.8M | Buy |
+816,463
| New | +$46.2M | 0.36% | 69 |
|
|
2014
Q4 | – | Sell |
-268,812
| Closed | -$15.2M | – | 784 |
|
|
2014
Q3 | $15.2M | Buy |
+268,812
| New | +$15.1M | 0.12% | 215 |
|
|
2014
Q2 | – | Sell |
-203,373
| Closed | -$11M | – | 719 |
|
|
2014
Q1 | $11M | Sell |
203,373
-220,668
| -52% | -$11.4M | 0.13% | 211 |
|
|
2013
Q4 | $20.3M | Sell |
424,041
-380,388
| -47% | -$17.4M | 0.26% | 104 |
|
|
2013
Q3 | $36.5M | Buy |
+804,429
| New | +$36.7M | 0.49% | 33 |
|
Other funds holding MRK
VCM
VPM
Balyasny Asset Management's MRK Position: Q1 2026 in Review
Balyasny Asset Management reduced its Merck (MRK) stake by 17% in Q1 2026, selling an estimated $43.3M and leaving 1,812,608 shares worth $218M. The position accounts for 0.28% of the portfolio, ranked #53.
Balyasny Asset Management first reported a position in MRK in Q3 2013 and has held it in 43 quarters since. The position peaked at $230M in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Balyasny Asset Management held 1,812,608 shares of Merck worth $218M as of Q1 2026.
- Balyasny Asset Management sold 374,652 Merck shares in Q1 2026, an estimated $43.3M.
- Merck made up 0.28% of Balyasny Asset Management's portfolio in Q1 2026, its #53 holding.
- Balyasny Asset Management first reported a position in Merck in Q3 2013 and has held it in 43 quarters since.
- Balyasny Asset Management's Merck position peaked at $230M in Q4 2025.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.